Inventor · disambiguated record
Barbara Slusher
Also filed as: SLUSHER BARBARA · SLUSHER BARBARA S · SLUSHER BARBARA STAUCH
80 granted patents·36 pending applications·2,341 citations·filing 1996–2024
99Inventor score
Files withUNIV JOHNS HOPKINS52GUILFORD PHARM INC46MGI GP INC2SLUSHER BARBARA S2ASHVATTHA THERAPEUTICS INC1
Top patents by PatentIndex Score
116 records- 0197US5968915ANaaladase inhibitorsGUILFORD PHARM INC·Filed 1997·Granted Oct 19, 1999·102 cites·14 claims
- 0296US5863536APhosphoramidate derivativesGUILFORD PHARM INC·Filed 1996·Granted Jan 26, 1999·121 cites·24 claims
- 0396US5672592ACertain phosphonomethyl-pentanedioic acid derivatives thereofGUILFORD PHARM INC·Filed 1996·Granted Sep 30, 1997·100 cites·11 claims
- 0495US6017903APharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitorsGUILFORD PHARM INC·Filed 1997·Granted Jan 25, 2000·88 cites·40 claims
- 0595US5880112ANaaladase inhibitorsGUILFORD PHARM INC·Filed 1997·Granted Mar 9, 1999·86 cites·9 claims
- 0694US10738066B2Prodrugs of glutamine analogsUNIV JOHNS HOPKINS·Filed 2019·Granted Aug 11, 2020·5 cites·18 claims
- 0794US10336778B2Prodrugs of glutamine analogsUNIV JOHNS HOPKINS·Filed 2018·Granted Jul 2, 2019·8 cites·4 claims
- 0894US5795877AInhibitors of NAALADase enzyme activityGUILFORD PHARM INC·Filed 1996·Granted Aug 18, 1998·143 cites·24 claims
- 0993US10954257B2Prodrugs of glutamine analogsUNIV JOHNS HOPKINS·Filed 2019·Granted Mar 23, 2021·4 cites·19 claims
- 1093US6395718B1Pharmaceutical compositions and methods of inhibiting angiogenesis using naaladase inhibitorsGUILFORD PHARM INC·Filed 1998·Granted May 28, 2002·132 cites·46 claims
- 1193US6265609B1Thio-substituted pentanedioic acid derivativesGUILFORD PHARM INC·Filed 1999·Granted Jul 24, 2001·66 cites·35 claims
- 1293US5962521AHydroxamic acid derivativesGUILFORD PHARM INC·Filed 1997·Granted Oct 5, 1999·90 cites·35 claims
- 1392US10568868B2Methods and compositions for treating metabolic reprogramming disordersUNIV JOHNS HOPKINS·Filed 2018·Granted Feb 25, 2020·8 cites·19 claims
- 1491US10842763B2Methods for cancer and immunotherapy using prodrugs of glutamine analogsUNIV JOHNS HOPKINS·Filed 2019·Granted Nov 24, 2020·8 cites·16 claims
- 1591US9988407B2Prodrugs of prostate specific membrane antigen (PSMA) inhibitorUNIV JOHNS HOPKINS·Filed 2015·Granted Jun 5, 2018·11 cites·11 claims
- 1691US6011021AMethods of cancer treatment using naaladase inhibitorsGUILFORD PHARM INC·Filed 1997·Granted Jan 4, 2000·51 cites·32 claims
- 1791US5902817ACertain sulfoxide and sulfone derivativesGUILFORD PHARM INC·Filed 1997·Granted May 11, 1999·104 cites·17 claims
- 1890US6384022B1Prodrugs of NAALAdase inhibitorsGUILFORD PHARM INC·Filed 1997·Granted May 7, 2002·82 cites·85 claims
- 1990US6313159B1Metabotropic glutamate receptor ligand derivatives as naaladase inhibitorsGUILFORD PHARM INC·Filed 1999·Granted Nov 6, 2001·39 cites·22 claims
- 2090US6054444APhosphonic acid derivativesGUILFORD PHARM INC·Filed 1997·Granted Apr 25, 2000·83 cites·33 claims
- 2189US11325931B2Prodrugs of prostate specific membrane antigen (PSMA) inhibitorUNIV JOHNS HOPKINS·Filed 2020·Granted May 10, 2022·2 cites·19 claims
- 2289US6586623B2Thiol-based NAALADase inhibitorsGUILFORD PHARM INC·Filed 2002·Granted Jul 1, 2003·25 cites·25 claims
- 2389US6452044B2Benzenedicarboxylic acid derivativesGUILFORD PHARM INC·Filed 2001·Granted Sep 17, 2002·28 cites·38 claims
- 2489US6025345AInhibitors of NAALADase enzyme activityGUILFORD PHARM INC·Filed 1997·Granted Feb 15, 2000·46 cites·10 claims
- 2589US5824662ATreatment of global and focal ischemia using naaladase inhibitorsGUILFORD PHARM INC·Filed 1996·Granted Oct 20, 1998·74 cites·12 claims
- 2689US5804602AMethods of cancer treatment using naaladase inhibitorsGUILFORD PHARM INC·Filed 1996·Granted Sep 8, 1998·90 cites·9 claims
- 2788US9382229B2Compounds and methods of use thereof for treating neurodegenerative disordersZACK DONALD J·Filed 2012·Granted Jul 5, 2016·6 cites·2 claims
- 2888US6046180ANAALADase inhibitorsGUILFORD PHARM INC·Filed 1997·Granted Apr 4, 2000·79 cites·7 claims
- 2988US5977090APharmaceutical compositions and methods of treating compulsive disorders using NAALADase inhibitorsGUILFORD PHARM INC·Filed 1997·Granted Nov 2, 1999·79 cites·44 claims
- 3087US6348464B1Pyrrolecarbonylimino derivatives as naaladase inhibitorsGUILFORD PHARM INC·Filed 1999·Granted Feb 19, 2002·35 cites·23 claims
- 3183US11059775B2Prodrug compositions and utility of hydroxamate-based GCPII inhibitorsUNIV JOHNS HOPKINS·Filed 2017·Granted Jul 13, 2021·2 cites·1 claims
- 3282US11331271B2Buccal, sublingual and intranasal delivery of fospropofolUNIV JOHNS HOPKINS·Filed 2017·Granted May 17, 2022·2 cites·20 claims
- 3382US10849915B2Methods for treating inflammatory bowel disease using prostate specific membrane antigen (PSMA) inhibitorsUNIV JOHNS HOPKINS·Filed 2018·Granted Dec 1, 2020·3 cites·3 claims
- 3482US6025344ACertain dioic acid derivatives useful as NAALADase inhibitorsGUILFORD PHARM INC·Filed 1997·Granted Feb 15, 2000·45 cites·25 claims
- 3581US6376478B1Pharmaceutical compositions and methods for treating anxiety, anxiety disorders and memory impairment using naaladase inhibitorsGUILFORD PHARM INC·Filed 2000·Granted Apr 23, 2002·10 cites·12 claims
- 3681US6271245B1Hydroxamic acid derivativesGUILFORD PHARM INC·Filed 1999·Granted Aug 7, 2001·37 cites·11 claims
- 3780US10544176B2Prodrugs of prostate specific membrane antigen (PSMA) inhibitorUNIV JOHNS HOPKINS·Filed 2018·Granted Jan 28, 2020·2 cites·4 claims
- 3880US6071965APhosphinic alkanoic acid derivativesGUILFORD PHARM INC·Filed 1997·Granted Jun 6, 2000·58 cites·20 claims
- 3979US6372726B1Methods of cancer treatment using NAALADase inhibitorsGUILFORD PHARM INC·Filed 1999·Granted Apr 16, 2002·35 cites·12 claims
- 4078US12492160B2Prodrugs of itaconate and methyl itaconateUNIV JOHNS HOPKINS·Filed 2024·Granted Dec 9, 2025·0 cites·11 claims
- 4178US11932664B2Prodrugs of prostate specific membrane antigen (PSMA) inhibitorUNIV JOHNS HOPKINS·Filed 2022·Granted Mar 19, 2024·0 cites·9 claims
- 4278US11110104B2Glutamine antagonists for the treatment of cognitive deficits and psychiatric disordersUNIV JOHNS HOPKINS·Filed 2018·Granted Sep 7, 2021·2 cites·13 claims
- 4378US7553866B2ThiolactonesEISAI CORP NORTH AMERICA·Filed 2007·Granted Jun 30, 2009·2 cites·14 claims
- 4478US6812364B2Thiol-based NAALADase inhibitorsGUILFORD PHARM INC·Filed 2003·Granted Nov 2, 2004·8 cites·10 claims
- 4578US6004946ATreatment of global and focal ischemia using naaladase inhibitorsGUILFORD PHARM INC·Filed 1997·Granted Dec 21, 1999·39 cites·5 claims
- 4677US10172873B2Methods for treating inflammatory bowel disease using prostate specific membrane antigen (PSMA) inhibitorsUNIV JOHNS HOPKINS·Filed 2015·Granted Jan 8, 2019·2 cites·16 claims
- 4776US12496284B2Use of itaconate and its derivatives/analogues to induce hair growthUNIV JOHNS HOPKINS·Filed 2024·Granted Dec 16, 2025·0 cites·16 claims
- 4875US11926640B2Prodrugs of glutamine analogsUNIV JOHNS HOPKINS·Filed 2021·Granted Mar 12, 2024·0 cites·16 claims
- 4975US6228888B1Methods for treating anxiety, anxiety disorders and memory impairment using naaladase inhibitorsGUILFORD PHARM INC·Filed 1999·Granted May 8, 2001·26 cites·10 claims
- 5074US6458775B1NAALADase inhibitors useful as pharmaceutical compounds and compositionsGUILFORD PHARM INC·Filed 1999·Granted Oct 1, 2002·30 cites·55 claims
Showing the top 50 of 116 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →